Optimizing first-line therapy for double-expressor lymphoma: a systematic review and meta-analysis of novel agent-augmented R-CHOP regimens.
APA
Zhang MY, Xiao F, et al. (2026). Optimizing first-line therapy for double-expressor lymphoma: a systematic review and meta-analysis of novel agent-augmented R-CHOP regimens.. Cancer cell international. https://doi.org/10.1186/s12935-026-04293-4
MLA
Zhang MY, et al.. "Optimizing first-line therapy for double-expressor lymphoma: a systematic review and meta-analysis of novel agent-augmented R-CHOP regimens.." Cancer cell international, 2026.
PMID
41943110
같은 제1저자의 인용 많은 논문 (4)
- Synergistic antitumor effect of oroxylin A and donafenib in hepatocellular carcinoma through tumor protein p53 signaling pathway activation.
- Euscaphic Acid from Rosa roxburghii Tratt Exerts Anti-colorectal Cancer Activity by Inducing Mitochondrial Apoptosis through ROS/MAPK Pathway.
- Meta-analysis of comparing CAR-T and bispecific antibody therapy in relapsed/refractory indolent B-cell non-Hodgkin's lymphomas.
- [Immediate repair of post-operative defect of oral and maxillofacial soft tissue (author's transl)].